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Abstract
Flavonoids probably contribute to the health benefits associated with the consumption of fruit and vegetables. However,
the mechanisms by which they exert their effects are not fully elucidated. PUFA of the (n-3) series also have health
benefits. Epidemiological and clinical studies have suggested that wine flavonoids may interact with the metabolism of
(n-3) PUFA and increase their blood and cell levels. The present studies in rats were designed to assess whether
flavonoids actually increase plasma levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the main very
long-chain (n-3) PUFA. Rats were fed a corn-derived anthocyanin (ACN)-rich (ACN-rich) or ACN-free diet with constant
intakes of plant and marine (n-3) PUFA for 8 wk (Expt. 1). Plasma fatty acids were measured by GC. The ACN-rich diet
contained;0.246 0.01mg of ACN/g pellets. Therewere no significant differences between groups in themain saturated,
monounsaturated, and (n-6) fatty acids. In contrast, plasma EPA and DHA were greater in the ACN-rich diet group than in
the ACN-free diet group (P , 0.05). We obtained similar results in 2 subsequent experiments in which rats were
administered palm oil (80 mL/d) and consumed the ACN-rich or ACN-free diet (Expt. 2) or were supplemented with fish oil
(60 mg/d, providing 35 mg DHA and 12 mg EPA) and consumed the ACN-rich or ACN-free diet (Expt. 3). In both
experiments, plasma EPA and DHA were significantly greater in the ACN-rich diet group. These studies demonstrate that
the consumption of flavonoids increases plasma very long-chain (n-3) PUFA levels. These data confirm previous clinical
and epidemiological studies and provide new insights into the health benefits of flavonoids. J. Nutr. 141: 37–41, 2011.
Introduction
Flavonoids are plant-derived bioactive compounds that include a
large group of molecules commonly found in human foods and
beverages such as berries, apples, onions, cocoa, tea, or wine (1).
Epidemiological studies have suggested beneficial health effects of
the chronic consumption of flavonoid-rich foods (2–4). Although
the health effects of flavonoids have been mostly attributed to
their antioxidant properties (5), the exact mechanisms by which
they exert their health effects have not been fully elucidated so far.
PUFA of the (n-3) series are also associated with major health
benefits, in particular the very long-chain eicosapentaenoic acid
(EPA)6 and docosahexaenoic acid (DHA), also called marine
(n-3) PUFA, because they are present in large amounts in fatty
fish (6,7). We have recently reported increased concentrations of
EPA and DHA in the blood and cells of wine drinkers (8,9).
These studies have indicated that components of wine other than
ethanol, such as flavonoids, are probably responsible for these
effects (8,9). If the effect of flavonoids on EPA and DHA is
confirmed, the consequences may be considerable in terms of
aquaculture and sea farming as well as human and animal
nutrition and medicine. However, although the “fish-like" effect
of moderate wine drinking has been clearly demonstrated (8),
the interaction between flavonoids and (n-3) PUFA in the
absence of ethanol has not yet been investigated.
The present study was therefore designed to assess whether
the chronic consumption of plant-derived flavonoids such as
anthocyanin (ACN) actually increases blood EPA and DHA
levels in rats. Using a well-controlled experimental model (10),
we assessed the changes in plasma fatty acid composition in rats
fed an ACN-rich or ACN-free diet. Because the whole diet,
especially fat intake, may play an important role in the
interactions between ACN and (n-3) PUFA metabolism, we
also analyzed the effect of ACN in rats exposed to diets enriched
in either saturated fats (palm oil) or fish oil.
Materials and Methods
A total of 90 male Wistar rats (1 mo old, baseline body weight 75–100 g)
were purchased from Charles River Laboratories. The rats were fed a
standard diet (A04, SAFE) while acclimating and before being distributed
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into 3 experimental groups. The animals were cared for according to the
EuropeanCouncil Directive 86/609/EEC on the care and use of laboratory
animals (OJ L 358). The protocols were performed under license from the
FrenchMinistry of Agriculture (license no. A380727) and approved by the
local animal ethics committee. The rats were housed under conditions
of constant temperature, humidity, and a standard light-dark cycle (12 h/
12 h). The rats consumed ad libitum food and tap water.
Food preparation for ACN supply. Rodent food pellets enriched (or
not) in ACN were prepared as previously described (10) using
nongenetically modified corn lines selected from germplasm collections.
Briefly, the ACR corn genotype carried the R-r allele, conferring high
ACN accumulation and purple pigmentation to the aleurone of the seed,
whereas the r-D902 genotype (referred to herein as r1) carried an
interstitial deletion involving a region of the long arm of chromosome 10
containing the r1 locus (10). To obtain ears with a high kernel yield, the
ACR and r1 genotypes were crossed with a commercial hybrid stock and
the F1 progeny seed was used to produce 2 synthetic populations
differing only in their r1 constitution (10). Special diets were prepared by
replacing the corn content (20%of the total) of a standard pellet formula
(A04, SAFE) with corn seed powder obtained from the r1 or ACR
synthetic populations to produce the ACN-rich and ACN-free diets,
respectively. Both diets had the same energy content, with macronutrient
concentrations of 67% carbohydrate, 23% protein, and 10% lipids
(SAFE). Both the ACN-rich and ACN-free diets were similar in terms of
fatty acid composition, as detailed in Table 1.
Experimental protocol. Three experiments were conducted succes-
sively using 3 different groups of rats. Expt. 1: To test the effects of ACN
in rats fed a standard diet, the rats were randomized into 2 experimental
groups (n = 15/group) for an 8-wk feeding trial during which they
received either the ACN-free or the ACN-rich diet. Expt. 2: To test the
effects of ACN in rats fed a saturated fat-rich diet, they were fed either
the ACN-free or the ACN-rich diet in combination with a daily oral
administration of palm oil (80 mL/d,Marka) in both groups for 8 wk (n =
15/group). In addition to the standard diet, palm oil provided 37 mg/d of
SFA, 28 mg/d of monounsaturated fatty acids, and 7 mg/d of PUFA. The
palm oil contained no EPA or DHA. Expt. 3: To test the effects of ACN
in rats fed an (n-3) PUFA-rich diet, they were fed either the ACN-free or
the ACN-rich diet in combination with daily oral administration of fish
oil (60 mg/d; IsodisNatura) in both groups supplying ;35 mg/d DHA
and 12 mg/d EPA for 8 wk (n = 15/group).
During the 3 experiments, body weight and food consumption were
recorded weekly. After 8 wk in all experiments, rats were anesthetized
and heparinized (100 IU/100 g body weight). Plasma was obtained after
centrifugation (5 min, 10003 g, 48C). Samples were stored at –808C for
subsequent fatty acid analyses.
Lipid and fatty acid analyses. Plasma lipids were extracted in hexane/
isopropanol as described previously (11). Briefly, methylated fatty acids
were extracted with hexane, separated, and quantified by GC using a 6850
Series gas chromatograph system (Agilent Technologies). Methyl ester
peaks were identified by comparing their retention time to those of a
standard mixture. Saturated, mono-, and poly-unsaturated fatty acid levels
were expressed as a percentage of total fatty acid content. Total cholesterol,
HDL cholesterol, and triglycerides were measured using standard clinical
methodology on a Synchron Clinical System LX20 (Beckman Coulter).
Statistical analysis. The data are expressed as means 6 SEM. The 3
experimental protocols were not conducted at the same period of time
and comparisons were made only between groups within each protocol.
Differences between groups were evaluated using unpaired Student’s t
test. P , 0.05 was considered significant.
Results
ACN content of the food pellets. As previously reported (10),
HPLC analyses showed that ACN were detected in the ACN-
rich seeds but were entirely absent from the ACN-free maize
seeds. The same ACN remained in the food pellets. Quantitative
analyses indicated that the ACN-rich diet contained ;0.24 6
0.01 mg of ACN/g of food pellets.
Body weight and food consumption. In Expt. 1, body weight
(data not shown) and daily food consumption did not differ
between the ACN-free (22.0 6 0.4 g) and ACN-rich (21.8 6
0.3 g) diet groups. In rats supplemented with palm oil (Expt. 2),
body weight (data not shown) and daily food intake did not
differ between the ACN-free+palm oil (23.4 6 0.8 g) and the
ACN-rich+palm oil (23.3 6 1.1 g) groups. In Expt. 3, body
weight (data not shown) and daily food consumption did not
differ between the rats receiving the ACN-free+fish oil (21.8 6
0.6 g) and the ACN-rich+fish oil (22.0 6 0.3 g) diet.
Plasma lipid concentrations. Cholesterol and triglyceride
concentrations did not significantly differ in the rats in Expt.
1 fed the ACN-free and the ACN-rich diets (Table 2). Similarly,
levels of the main SFA, oleic acid, arachidonic acid, total levels of
saturated and monounsaturated fatty acids, and total (n-6) PUFA
did not differ between the ACN-rich and ACN-free groups. In
contrast, total (n-3) PUFA and the (n-3):(n-6) fatty acid ratio were
significantly greater in rats fed the ACN-rich diet (P , 0.01).
Plasma EPA and DHA concentrations were greater in rats fed the
ACN-rich diet than in those fed the ACN-free diet (P , 0.05).
In Expt. 2, in which both groups received palm oil, the
plasma cholesterol, triglycerides, and saturated, monounsatu-
rated, total (n-6), and total (n-3) fatty acid concentrations did
not differ between the rats receiving the ACN-free and the ACN-
rich diet (Table 3). However, the plasma (n-3):(n-6) fatty acid
ratio and EPA and DHA concentrations were greater in rats fed
the ACN-rich diet than in rats fed the ACN-free diet (P, 0.05).
In Expt. 3, in which both groups received fish oil, the plasma
cholesterol, triglycerides, and saturated, monounsaturated, and
total (n-6) fatty acid concentrations did not differ between the
rats receiving the ACN-free and the ACN-rich diet (Table 4).
However, total (n-3) fatty acid concentrations, the (n-3):(n-6)
fatty acid ratio, and EPA and DHA concentrations were greater
in rats fed the ACN-rich diet than in rats fed the ACN-free diet
(P , 0.05).
TABLE 1 Fatty acid composition of the ACN-free
and ACN-rich diets
Fatty acid mg/100 g food
14:0 20
16:0 520
18:0 50
20:0 10
18:1(n-9) 400
16:1(n-7) 20
18:2(n-6) 1310
20:4(n-6) 0
18:3(n-3) 110
20:5(n-3) 20
22:5(n-3) 10
22:6(n-3) 30
Total SFA 620
Total MUFA1 510
Total PUFA 1480
Total (n-3) 170
Total (n-6) 1310
1 MUFA, total monounsaturated fatty acids.
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Discussion
For the first time, to our knowledge, in well-controlled exper-
imental conditions, the present study shows that dietary plant-
derived ACN modulate the metabolism of (n-3) PUFA and
increase plasma concentrations of the very long-chain (n-3)
PUFA, EPA and DHA, also called marine (n-3) fatty acids. This
was also observed in rats consuming an ACN-rich diet combined
with either saturated fat (palm oil, Expt. 2) or fish oil (Expt. 3).
In the 3 experiments, EPA increased more (41, 25, and 24%)
than DHA (16, 10, and 16%), although the increase was
significant for both fatty acids. The different increases for EPA
and DHA were not unexpected, because the synthesis of DHA
involves additional steps, (double) carbonyl chain elongation,
desaturation, and b-oxidation, compared with that of EPA from
the plant precursor, a-linolenic acid (12). The different increases
in EPA and DHA suggest, but do not definitely demonstrate, that
ACN may exert their effects through the conversion pathway of
a-linolenic acid into the very long-chain EPA and DHA. An
alternative mechanism, increased intestinal absorption of EPA
and DHA, would (at least in theory) induce a parallel increase in
EPA, DHA, and some other fatty acids, including (n-6) PUFA.
However, this did not happen. Also, in case of increased
intestinal absorption of EPA and DHA in the presence of dietary
ACN, we would have observed the strongest EPA and DHA
increases among rats receiving fish oil, because more EPA and
DHA were available in the intestinal tract of these rats. Again,
this was not the case.
The different increases in EPA and DHA levels were also not
unexpected because of the quite short (8 wk) duration of the
feeding periods in this study. In fact, we speculate that the
stimulation of a more complex pathway (the synthesis of DHA
from a-linolenic acid) would require more time to see large
effects on DHA than the stimulation of the shortest pathway
from a-linolenic acid to EPA.
Further studies with longer feeding periods are therefore
required to monitor the rate and cofactors of this newly
described process and to study the accumulation of EPA and
DHA in specific cells and tissues, including RBC, leukocytes,
brain, heart, and kidney.
Clinical implications. ACN are a large group of water-soluble
plant pigments that belong to the flavonoid family (1,13).
Epidemiological, clinical, and experimental evidence suggests
that dietary flavonoids, including flavones, flavonols, and ACN,
may exert beneficial health effects (4,10,14–16). For instance,
we previously demonstrated that the regular consumption of
ACN protects rats’ hearts against both ex vivo and in vivo
ischemia-reperfusion injury (10). In these cardiac experiments,
as in the present study, corn-derived ACNwere included into the
standard diet to produce an ACN-rich diet and isogenic corn
seeds free of ACN were added to the control (ACN-free) diet
(10). The main ACN identified in the ACN-rich corn and also in
the corresponding ACN-rich pellets, cyanidin-glucoside, cyanidin-
malonylglucoside, cyanidin-dimalonylglucoside, and pelargonidin-
malonylglucoside, were detected only in the urine samples of rats
fed the ACN-rich diet (10). This food model therefore allowed
studying the specific effects of the ACN identified in the ACN-
rich corn selected for our studies. Because the corn used in the
control group is isogenic to the ACN-rich corn, this experimen-
tal model almost totally excludes that the effects associated with
consumption of ACN-rich corn, e.g. the metabolism of (n-3)
PUFA and myocardial ischemia-reperfusion injury, were caused
by some unidentified factors or cofactors (other than ACN)
present in ACN-rich but not in ACN-free corn.
In this study in rats, we observed a marked increase in plasma
EPA and DHA, fatty acids known to be protective against heart
disease complications (6,7). Moderate wine consumption, also
known to be cardioprotective (17,18), has been associated with
TABLE 2 Plasma lipids and fatty acid concentrations in rats fed
ACN-free or ACN-rich diets for 8 wk (Expt. 1)1
ACN-free ACN-rich
Lipids, mmol/L
Total cholesterol 1.06 6 0.18 1.29 6 0.05
HDL cholesterol 0.95 6 0.05 1.01 6 0.05
Triglycerides 1.52 6 0.31 1.17 6 0.29
Fatty acids, % of total fatty acids
Myristic 0.8 6 0.1 0.7 6 0.1
Palmitic 21.9 6 0.6 20.6 6 0.7
Stearic 6.3 6 0.4 6.0 6 0.4
Oleic 12.8 6 0.7 11.9 6 1.1
Linoleic 23.4 6 0.9 23.8 6 0.5
a-Linolenic 0.7 6 0.1 0.8 6 0.1
Arachidonic 16.1 6 1.6 17.5 6 1.7
EPA 0.9 6 0.03 1.2 6 0.09**
Docosapentaenoic 0.6 6 0.05 0.7 6 0.05
DHA 3.8 6 0.2 4.5 6 0.2*
Total SFA 29.1 6 0.6 27.4 6 0.6
Total MUFA 23.5 6 1.4 22.4 6 1.8
Total PUFA 47.2 6 1.6 50.0 6 2.1
Total (n-3) 6.1 6 0.2 7.2 6 0.2**
Total (n-6) 41.1 6 1.4 42.8 6 1.9
(n-3):(n-6) fatty acids 0.15 6 0.0 0.17 6 0.0**
1 Values are means6 SEM, n = 15 per group. Asterisks indicate difference from ACN-
free: *P , 0.05, **P , 0.01.
TABLE 3 Plasma lipids and fatty acid concentrations in rats fed
a ACN-free or ACN-rich diet and supplemented with
palm oil for 8 wk (Expt. 2)1
ACN-free+palm oil ACN-rich+palm oil
Lipids, mmol/L
Total cholesterol 1.01 6 0.05 1.08 6 0.05
HDL cholesterol 0.82 6 0.03 0.90 6 0.05
Triglycerides 0.63 6 0.10 0.64 6 0.08
Fatty acids, % of total fatty acids
Myristic 1.0 6 0.1 1.1 6 0.1
Palmitic 22.6 6 0.3 22.9 6 0.6
Stearic 7.7 6 0.4 8.0 6 0.7
Oleic 11.3 6 0.7 11.2 6 0.6
Linoleic 20.3 6 0.4 19.7 6 0.7
a-Linolenic 0.5 6 0.1 0.4 6 0.0
Arachidonic 18.8 6 1.1 17.1 6 1.1
EPA 1.3 6 0.07 1.6 6 0.09*
Docosapentaenoic 0.9 6 0.05 0.9 6 0.05
DHA 4.9 6 0.1 5.4 6 0.2*
Total SFA 31.4 6 0.6 32.0 6 0.9
Total MUFA 19.9 6 1.1 20.5 6 1.3
Total PUFA 48.5 6 1.2 46.8 6 1.6
Total (n-3) 7.6 6 0.2 8.3 6 0.4
Total (n-6) 40.9 6 1.1 38.5 6 1.4
(n-3):(n-6) fatty acids 0.19 6 0.0 0.22 6 0.0*
1 Values are means 6 SEM, n = 15 per group. *Different from ACN-free, P , 0.05.
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increased levels of EPA and DHA in patients with heart disease,
a phenomenon referred to as a fish-like effect of moderate wine
drinking (8). Moreover, in the IMMIDIET cohort, a significant
association between ethanol intake and EPA and DHA levels
was shown among wine drinkers, whereas no significant asso-
ciation was found among beer or spirits drinkers (9). These data
strongly suggested that some components of wine other than
ethanol (e.g. ACN) were mainly responsible for the association
between wine drinking and (n-3) PUFA.
Thus, our present experimental data confirm that, indepen-
dently from their consumption through alcoholic beverages (i.e.
in the absence of ethanol), food-derived ACN interfere with the
metabolism of (n-3) PUFA and induce their accumulation in
blood. Whereas the health-promoting effects of flavonoids were
originally attributed mostly to their antioxidant properties, there
is increasing evidence that many of their biological effects are
related to their ability to modulate mammalian cell signaling
pathways (19). The interactions between ACN and (n-3) PUFA
in this study provide totally new insights into the potential
mechanisms of protection afforded by dietary flavonoids.
The next question is whether the changes observed in this
study are biologically or clinically important. Although rat data
should be prudently extrapolated to the human situation, and
vice versa, the present consensus about long-chain marine (n-3)
fatty acids is that small changes result in large clinical effects,
especially in populations with low consumption of both plant
and marine (n-3) fatty acids. Thus, a 40% increase in plasma
EPA associated with a 16% increase in DHA in this study is not
anecdotal. In human studies, similar and even smaller changes in
marine (n-3) have been associated with significant reduction of
the risk of coronary heart disease complications (8,20).
Finally, it should be noted that the average intake of ACN in
Western populations is estimated to be 12 mg/d (10), equivalent
to a daily intake of 6 mg/(kcal×d)7 assuming a daily energy intake
of 2000 kcal. Because we calculated that rats fed the ACN-rich
diet received ;0.08 mg/(kcal×d) ACN (10), they received ~13-
fold more ACN than most people consuming a standardWestern-
type diet (10). In contrast, many typical Mediterranean foods
and beverages (fruits, vegetables, and wine, for instance) are rich
in ACN and the ACN content of the traditional Mediterranean
diet is much higher than that of the Western diet, which might
partly explain why the Mediterranean diet is cardioprotective
(21).
Potential mechanisms. Beside the above-discussed possibility
that ACN increase the intestinal absorption of EPA and DHA,
the main hypothesis regarding the effect of ACN on (n-3) PUFA
is that they may accelerate the synthesis of EPA and DHA from
their precursor a-linolenic acid, the main (n-3) PUFA in the diet
of both rats and humans (12,22). The dietary intakes of a-
linolenic acid did not differ in rats fed the ACN-free or ACN-rich
diet in our 3 experiments, which again suggests that increased
EPA and DHA levels resulted from the activation of their bio-
synthesis from a-linolenic acid. Two desaturases, D6 and D5,
are required for EPA formation from a-linolenic acid, with D6
desaturase being the rate-limiting step in the pathway (12).
Whereas (n-3) and (n-6) PUFA are in competition for desatura-
tion and elongation, D6 desaturase is thought to preferentially
use (n-3) PUFA (12,23), which may explain why we did not detect
any change in the levels of (n-6) PUFA, in particular arachidonic
acid, in our 3 experiments. Both microsomal enzymes are reg-
ulated by genetics, nutrition, and hormonal status (24,25).
Whether flavonoids influence D6 or D5 desaturase or both re-
quires further studies. It is noteworthy that the metabolic bene-
fits induced by several classes of flavonoids have been linked at
least partly to a PPARa-dependent mechanism that also interferes
with the PUFA elongation-desaturation pathway (26–28). For
example, PPARa activators, such as the cholesterol-lowering
drugs fibrates, have been shown to upregulate hepatic D6 de-
saturase expression and activity (29). However, we have shown
in a randomized trial in patients that fenofibrate actually de-
creases rather than increases EPA and DHA levels (30). At the
same time, fenofibrate significantly increases arachidonic acid
levels, which was not the case with ACN in the present study. It
is therefore unlikely that ACN may increase EPA and DHA
levels through a PPARa-dependent mechanism. Further studies
are required to determine the exact mechanism by which ACN
consumption modulates plasma EPA and DHA concentration
increases.
Compared with rats fed the ACN-free diet plus palm oil or
fish oil, the rats fed the ACN-rich diet plus palm oil or fish oil
had higher plasma EPA and DHA levels in the present study.
These data confirm that the effect of ACN on EPA and DHA
levels is relatively independent from other fat supplies. Xiang
et al. (31) have shown that high dietary intake of saturated fat
increases the expression of both D5 and D6 desaturase genes in
peripheral blood mononuclear cells in humans, suggesting that
both (n-3) and (n-6) PUFA biosynthesis may be modulated by
saturated fat. However, in the rats receiving palm oil in our
study, ACN specifically increased (n-3) PUFA levels without an
effect on (n-6) PUFA levels. This suggests that the mechanisms
by which ACN interfere with the metabolism of PUFA are
different from those involved in the saturated fat stimulation
described by Xiang et al. (31). In our study, fish oil induced a
marked accumulation of plasma EPA and DHA in both the
ACN-rich and ACN-free groups. This was expected. In that
specific nutritional condition, however, EPA and DHA increased
significantly more in the ACN-rich than in the ACN-free group.
TABLE 4 Plasma lipids and fatty acid concentrations in rats fed
a ACN-free or ACN-rich diet and supplemented with
fish oil for 8 wk (Expt. 3)1
ACN-free+fish oil ACN-rich+fish oil
Lipids, mmol/L
Total cholesterol 0.95 6 0.03 0.90 6 0.05
HDL cholesterol 0.80 6 0.03 0.72 6 0.05
Triglycerides 0.41 6 0.0 0.51 6 0.06
Fatty acids, % of total fatty acids
Myristic 0.9 6 0.1 0.8 6 0.1
Palmitic 22.4 6 0.3 21.9 6 0.7
Stearic 7.9 6 0.3 7.9 6 0.5
Oleic 9.3 6 0.3 10.1 6 0.4
Linoleic 21.9 6 0.6 20.8 6 0.7
a-Linolenic 0.4 6 0.0 0.4 6 0.0
Arachidonic 14.4 6 0.5 12.9 6 0.9
EPA 4.1 6 0.2 5.1 6 0.4*
Docosapentaenoic 1.4 6 0.1 1.6 6 0.1*
DHA 7.7 6 0.3 9.0 6 0.3**
Total SFA 31.3 6 0.5 30.7 6 1.0
Total MUFA 16.8 6 0.6 17.7 6 0.9
Total PUFA 51.6 6 1.0 51.4 6 1.6
Total (n-3) 13.6 6 0.5 16.1 6 0.6**
Total (n-6) 38.0 6 0.9 35.4 6 1.6
(n-3):(n-6) fatty acids 0.36 6 0.02 0.47 6 0.36**
1 Values are means 6 SEM. Asterisks indicate difference from ACN-free: *P , 0.05,
**P , 0.01.
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Limitations of the study. As discussed above, the present
experiments were performed in rats, so our data have yet to be
confirmed in humans. It is noteworthy, however, that previous
studies (8,9) have suggested that a comparable phenomenon
occurs in humans. In addition, our experiments were conducted
in male rats exclusively, which raises a gender issue. Gender
differences in the efficiency of (n-3) PUFA bioconversion have
been reported and might reflect differential hormonal regulation
of PUFA metabolism (12). In the present study, gender-related
differences were not evaluated and further studies are needed to
examine whether hormonal status may significantly modulate
the interactions between ACN and (n-3) PUFA. Also, our nutri-
tional protocols were conducted in young rats (from 1 to 3mo old).
However, the impact of ACN consumption on PUFA levels may
change with age both in rats and humans. Further studies are
also needed to examine this important issue.
In conclusion, our data show that dietary flavonoids, and
more specifically ACN consumption, interact with the metab-
olism of (n-3) PUFA and increase blood EPA and DHA levels.
The effect was observed for various dietary conditions, including
fat sources. Although the exact mechanisms involved in these
interactions are not yet understood, our results provide new
insights into the cellular pathways of the health benefits afforded
by dietary flavonoids.
Acknowledgments
We thank Katia Petroni and Roberto Pilu (from the Diparti-
mento di Scienze Biomolecolari e Biotecnologie in Milano) for
their help in providing the ACN-rich corn line. M.C.T., P.S., and
M.d.L. designed, conducted, and analyzed the research; P.S. and
M.d.L. wrote the paper; F.L. was in charge of the fatty acid
measurements and had primary responsibility for final content
of the paper; C.T. provided the ACN-rich corn line and had
primary responsibility for final content of the paper. All authors
read and approved the final manuscript.
Literature Cited
1. Manach C, Scalbert A, Morand C, Re´me´sy C, Jime´nez L. Polyphenols:
food sources and bioavailability. Am J Clin Nutr. 2004;79:727–47.
2. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic
studies. Am J Clin Nutr. 2005;81 Suppl:S317–25.
3. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA,
Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: a
prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:
895–909.
4. Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J,
Harnly J, Hollman P, Keen CL, et al. Flavonoids and heart health:
proceedings of the ILSI North America Flavonoids Workshop, May 31–
June 1, 2005, Washington, DC. J Nutr. 2007;137 Suppl:S718–37.
5. Terao J. Dietary flavonoids as antioxidants. Forum Nutr. 2009;61:
87–94.
6. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden
cardiac death by n-3 polyunsaturated fatty acids and mechanism of
prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:
2646–52.
7. McLennan P, Howe P, Abeywardena M, Raederstorff D, Mano M,
Rayner T, Head R. The cardiovascular protective role of docosahex-
anoic acid. Eur J Pharmacol. 1996;300:83–9.
8. de Lorgeril M, Salen P, Martin JL, Boucher F, de Leiris J. Interactions of
wine drinking with omega-3 fatty acids in patients with coronary heart
disease: a fish-like effect of moderate wine drinking. Am Heart J.
2008;155:175–81.
9. di Giuseppe R, de Lorgeril M, Salen P, Laporte F, di Castelnuovo A,
Krogh V, Siani A, Arnout J, Cappuccio FP, et al. Alcohol drinking and n-
3 polyunsaturated fatty acids in healthy men and women from 3
European populations. Am J Clin Nutr. 2009;89:354–62.
10. Toufektsian MC, de Lorgeril M, Nagy N, Salen P, Donati MB,
Giordano L, Mock HP, Peterek S, Matros A, et al. Chronic dietary
intake of plant-derived anthocyanins protects the rat heart against
ischemia-reperfusion injury. J Nutr. 2008;138:747–52.
11. Guiraud A, de Lorgeril M, Zeghichi S, Laporte F, Salen P, Saks V,
Berraud N, Boucher F, de Leiris J. Interactions of ethanol drinking with
n-3 fatty acids in rats: potential consequences for the cardiovascular
system. Br J Nutr. 2008;100:1237–44.
12. Burdge GC, Calder PC. Conversion of a-linolenic acid to longer-chain
polyunsaturated fatty acids in human adults. Reprod Nutr Dev.
2005;45:581–97.
13. Kong JM, Chia LS, Goh NK, Chia TF, Brouillard R. Analysis and
biological activities of anthocyanins. Phytochemistry. 2003;64:923–33.
14. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P,
Mattila P, Jula A. Favorable effects of berry consumption on platelet
function, blood pressure, and HDL cholesterol. Am J Clin Nutr.
2008;87:323–31.
15. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA,
Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and
cardiovascular risk: a meta-analysis of randomized controlled trials. Am
J Clin Nutr. 2008;88:38–50.
16. Sato M, Bagchi D, Tosaki A, Das DK. Grape seed proanthocyanidin
reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-
induced activation of JNK-1 and C-JUN. Free Radic Biol Med. 2001;31:
729–37.
17. Di Castelnuovo A, Rotondo S, Iacoviello L. Meta-analysis of wine and
beer consumption in relation to vascular risk. Circulation. 2002;105:
2836–44.
18. de Lorgeril M, Salen P, Martin JL. Wine drinking and risks of cardio-
vascular complications after recent acute myocardial infarction. Circu-
lation. 2002;106:1465–9.
19. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or
signalling molecules? Free Radic Biol Med. 2004;36:838–49.
20. Albert CM, Campos H, Stampfer MJ. Blood levels of long-chain n-3
fatty acids and the risk of sudden cardiac death. N Engl J Med.
2002;346:1113–8.
21. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N.
Mediterranean diet, traditional risk factors, and the rate of cardiovas-
cular complications after myocardial infarction: final report of the Lyon
Diet Heart Study. Circulation. 1999;99:779–85.
22. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid
ratio in cardiovascular disease and other chronic diseases. Exp Biol Med
(Maywood). 2008;233:674–88.
23. Das UN. A defective activity of D6 and D5 desaturases may be a factor
in the initiation and progression of atherosclerosis. Prostaglandins
Leukot Essent Fatty Acids. 2007;76:251–68.
24. Cho HP, Nakamura MT, Clarke SD. Cloning, expression, and nutri-
tional regulation of the mammalian delta-6 desaturase. J Biol Chem.
1999;274:471–7.
25. Cho HP, Nakamura M, Clarke SD. Cloning, expression, and fatty acid
regulation of the human delta-5 desaturase. J Biol Chem. 1999;274:
37335–9.
26. Kim S, Sohn I, Lee YS, Lee YS. Hepatic gene expression profiles are
altered by genistein supplementation in mice with diet-induced obesity.
J Nutr. 2005;135:33–41.
27. Li RW, Theriault AG, Au K, Douglas TD, Casaschi A, Kurowska EM,
Mukherjee R. Citrus polymethoxylated flavones improve lipid and
glucose homeostasis and modulate adipocytokines in fructose-induced
insulin resistant hamsters. Life Sci. 2006;79:365–73.
28. Mezei O, Li Y, Mullen E, Ross-Viola JS, Shay NF. Dietary isoflavone
supplementation modulates lipid metabolism via PPAR alpha-dependent
and -independent mechanisms. Physiol Genomics. 2006;26:8–14.
29. Matsuzaka T, Shimano H, Yahagi N, Amemiya-Kudo M, Yoshikawa T,
Hasty AH, Tamura Y, Osuga J, Okazaki H, et al. Dual regulation of
mouse delta-5 and delta-6 desaturase gene expression by SREBP-1 and
PPAR alpha. J Lipid Res. 2002;43:107–14.
30. de Lorgeril M, Salen P, Guiraud A, Zeghichi S, Boucher F, de Leiris J.
Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in
patients with coronary heart disease. Nutr Metab Cardiovasc Dis.
2005;15:36–41.
31. Xiang M, Rahman MA, Ai H, Li X, Harbige LS. Diet and gene
expression: delta-5 and delta-6 desaturases in healthy Chinese and
European subjects. Ann Nutr Metab. 2006;50:492–8.
Dietary flavonoids and (n-3) fatty acids 41
 by guest on July 30, 2013
jn.nutrition.org
D
ow
nloaded from
 
